Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06276361
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-02-16
Brief Title:
Pharmacokinetics Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone QUAR in Patients With Schizophrenia
Sponsor:
Organization:
Rovi Pharmaceuticals Laboratories